Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT06281886 · COMPLETED
Trial details
- NCT number
- NCT06281886
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2026-06-25
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.